J&J, Kenvue Forced to Pay $45 Million in Talc-Related Cancer Claims (NYSE:JNJ)

Johnson

Wachiwit Editorial/iStock via Getty Images

A Chicago jury ordered Johnson & Johnson (NYSE:JNJ) and its consumer support spin-off Kenvue (NYSE:KVUE) to pay $45 million to the family of an Illinois resident who died after developing cancer allegedly caused by the companies’ talc products

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *